Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Defined distribution and features of lymph node therapies enable recruitment and manipulation of antigen-specific T cell response

Molecular Therapy(2025)10.1016/j.ymthe.2025.10.026Source: DataRank Database

Defined distribution and features of lymph node therapies enable recruitment and manipulation of antigen-specific T cell response is a research paper published in Molecular Therapy (2025). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (13 grants)Impact (FWCI 0.00)OA: hybridTopics (42)IDs (PubMed, PMC, OpenAlex)Annotations (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (13)

Senta M. Kapnick ORCID,Sean T. Carey ORCID,Ryan A. McIlvaine ORCID,Yuan Rui ORCID,Haleigh B. Eppler ORCID

Live enrichment

PubMed:41172992 PMC:PMC12685280 OpenAlex:https://openalex.org/W4415703472

U.S. Department of Veterans Affairs

Grant: IK2BX005756

U.S. Department of Veterans Affairs

Grant: F31AI150198

National Institutes of Health

Grant: R01AI144667

National Institutes of Health

Grant: R01EB26896

National Institutes of Health

Grant: R01AI69686

Juvenile Diabetes Research Foundation International

Grant: 3-SRA-2023-1309-S-B

NIBIB NIH HHS

Grant: R01 EB026896

NIAID NIH HHS

Grant: F32 AI069686

NIAID NIH HHS

Grant: R01 AI169686

NIAID NIH HHS

Grant: T32 AI089621

University of Maryland

Juvenile Diabetes Research Foundation Canada

School of Engineering, Monash University Malaysia

FWCI

0.00

Citation Percentile

0.2%

hybridLicense: cc-by

journalhttps://www.cell.com/molecular-therapy-family/molecular-therapy/pdf/S1525-0016(25)00847-0.pdf

publisherhttps://www.cell.com/molecular-therapy-family/molecular-therapy/pdf/S1525-0016(25)00847-0.pdf

publisherhttps://api.elsevier.com/content/article/PII:S1525001625008470?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1525001625008470?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.ymthe.2025.10.026

Fields of Study

Immunotherapy and Immune ResponsesCAR-T cell therapy researchMonoclonal and Polyclonal Antibodies ResearchLymph NodesAnimalsMiceImmunotherapyHumansAntigensT-LymphocytesDisease Models, AnimalT-Lymphocytes, RegulatoryMice, Inbred C57BLAutoimmunity

MeSH Terms

AnimalsAntigensDisease Models, AnimalHumansImmunotherapyLymph NodesMice, Inbred C57BLT-LymphocytesAutoimmunityT-Lymphocytes, RegulatoryMice

Keywords

T cellLymphLymph nodeImmune systemAutoimmune diseaseDiseaseAntigenInflammationToleranceAutoimmunityBiomaterialsMicroparticleTarget Product ProfileAntigen-specific TherapyImmune EngineeringClinical Manufacturing ControlLymph Node Therapies

Defined distribution and features of lymph node therapies enable recruitment and manipulation of antigen-specific T cell response

FAIR Checklist

Authors (13)

Funding (13 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)